The National Organization for the Reform of Marijuana Laws (NORML) has released their list of the “Top Ten Events in Marijuana Policy” for 2024. Found in 1970, NORML is the oldest marijuana reform group in the nation. Today, they released their list of the most important and impact marijuana-related studies of 2024. Below is that …
Category: Miscellaneous
Dec 26 2024
Become a Paid Marijuana Reviewer: Dozens of Job Opportunities Open in Florida, Maryland, New York, Virginia and D.C.
Toker’s Guide has opened up dozens of marijuana reviewer jobs in Florida, Maryland, Virginia, New York and Washington DC. “Toker’s Guide is a rapidly growing cannabis start-up helping people find the best weed in their area by utilizing reviews from local connoisseurs”, states the company’s job listing on Indeed. “We are looking for cannabis connoisseurs …
Dec 26 2024
The Most Popular Marijuana Sativas of 2024
Sativas have long been celebrated for their uplifting and energizing effects, making them a favorite among marijuana enthusiasts. In 2024, a mix of timeless classics and exciting newcomers have dominated the shelves of marijuana dispensaries and retail outlets. Below is a curated list of the most popular sativa and sativa-dominant strains of 2024. The strains’ …
Dec 23 2024
2024’s Most Popular Marijuana Strains
Marijuana enthusiasts have plenty of choices in 2024, with strains offering unique flavors, effects, and experiences. The 10 marijuana strains listed below have captivated users due to their standout qualities, with the list ranging from uplifting sativas to relaxing indicas. Using a combination of data provided by state regulatory agencies and Leafly, below are the …
Dec 22 2024
Oregon Continues to Have the Cheapest Legal Cannabis Prices in the U.S., Followed by Michigan and Massachusetts
Marijuana prices across the 23 states with legal recreational sales remain strikingly inconsistent, reflecting a range of local factors including regulations and tax structures. Using the most recent data from state regulatory agencies and the research firm Headset, this article highlights the states where consumers can find the lowest average prices for marijuana. Prices are …
Dec 22 2024
Top Marijuana Studies Published in 2024
Despite marijuana remaining a Schedule I drug on the federal level, 2024 has been a huge year for marijuana research. As marijuana moves closer to being rescheduled to Schedule III, the potential for easier and more comprehensive research on marijuana and its compounds appears to be on the horizon. While this change has not yet …
Dec 18 2024
Report: Industrial Hemp Market Valued at $5.6 Billion, to Reach $13.9 Billion by 2028
The global industrial hemp market, valued at $5.6 billion in 2024, is projected to grow to $13.9 billion by 2028, according to a report by Technavio. This marks a compound annual growth rate (CAGR) of 25.25% over the forecast period. The report attributes this growth to increased demand across industries such as textiles, food and …
Dec 18 2024
Nationwide Poll Finds Just 12% of Voters Believe Marijuana Should Be Illegal
A new nationwide poll from the Manhattan Institute reveals that most Americans favor legalizing marijuana for personal use, with 73% of respondents supporting some form of legalization. The poll sampled 2,304 respondents, with a balanced political demographic: 41% identified as conservative, 30% as moderate, and 29% as liberal. It found that 69% of respondents believe …
Dec 17 2024
November Marijuana Sales Reach $1.92 Billion Across Legal States
Legal marijuana states generated a combined $1.92 billion in sales in November, resulting in over $260 million in tax revenue. According to an analysis by The Marijuana Herald, the $1.92 billion is a modest increase from the $1.87 billion sold in October and the $1.88 billion sold in September, but remains slightly less than the …
Dec 16 2024
MindMed Launches Phase 3 Trials for LSD-Based Treatment to Tackle Anxiety Disorders, Announces First Patient Dosed
Mind Medicine Inc., a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that the first patient has been dosed in its Phase 3 Voyage study of MM120 ODT, a pharmaceutically optimized form of lysergide D-tartrate (LSD) for the treatment of GAD. Voyage is the first of two Phase 3 …